These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21191088)

  • 1. Dopaminergic neurons of system x(c)⁻-deficient mice are highly protected against 6-hydroxydopamine-induced toxicity.
    Massie A; Schallier A; Kim SW; Fernando R; Kobayashi S; Beck H; De Bundel D; Vermoesen K; Bannai S; Smolders I; Conrad M; Plesnila N; Sato H; Michotte Y
    FASEB J; 2011 Apr; 25(4):1359-69. PubMed ID: 21191088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MPTP-induced parkinsonism in mice alters striatal and nigral xCT expression but is unaffected by the genetic loss of xCT.
    Bentea E; Sconce MD; Churchill MJ; Van Liefferinge J; Sato H; Meshul CK; Massie A
    Neurosci Lett; 2015 Apr; 593():1-6. PubMed ID: 25766755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-dependent changes in striatal xCT protein expression in hemi-Parkinson rats.
    Massie A; Schallier A; Mertens B; Vermoesen K; Bannai S; Sato H; Smolders I; Michotte Y
    Neuroreport; 2008 Oct; 19(16):1589-92. PubMed ID: 18806690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of system Xc
    Dang DK; Shin EJ; Tran HQ; Kim DJ; Jeong JH; Jang CG; Nah SY; Sato H; Nabeshima T; Yoneda Y; Kim HC
    Neurochem Int; 2017 Sep; 108():254-265. PubMed ID: 28457879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and function of cystine/glutamate transporter in neutrophils.
    Sakakura Y; Sato H; Shiiya A; Tamba M; Sagara J; Matsuda M; Okamura N; Makino N; Bannai S
    J Leukoc Biol; 2007 Apr; 81(4):974-82. PubMed ID: 17200146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of levetiracetam target xCT in astrocytes in parkinsonian mice.
    Miyazaki I; Murakami S; Torigoe N; Kitamura Y; Asanuma M
    J Neurochem; 2016 Jan; 136(1):194-204. PubMed ID: 26485447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's disease.
    Francardo V; Recchia A; Popovic N; Andersson D; Nissbrandt H; Cenci MA
    Neurobiol Dis; 2011 Jun; 42(3):327-40. PubMed ID: 21310234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced expression of cystine/glutamate transporter in the lung caused by the oxidative-stress-inducing agent paraquat.
    Kobayashi S; Kuwata K; Sugimoto T; Igarashi K; Osaki M; Okada F; Fujii J; Bannai S; Sato H
    Free Radic Biol Med; 2012 Dec; 53(12):2197-203. PubMed ID: 23085521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the striatal 6-OHDA model of Parkinson's disease in wild type and alpha-synuclein-deleted mice.
    Alvarez-Fischer D; Henze C; Strenzke C; Westrich J; Ferger B; Höglinger GU; Oertel WH; Hartmann A
    Exp Neurol; 2008 Mar; 210(1):182-93. PubMed ID: 18053987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cooperative action of glutamate transporters and cystine/glutamate antiporter system Xc- protects from oxidative glutamate toxicity.
    Lewerenz J; Klein M; Methner A
    J Neurochem; 2006 Aug; 98(3):916-25. PubMed ID: 16771835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cystine/cysteine cycle: a redox cycle regulating susceptibility versus resistance to cell death.
    Banjac A; Perisic T; Sato H; Seiler A; Bannai S; Weiss N; Kölle P; Tschoep K; Issels RD; Daniel PT; Conrad M; Bornkamm GW
    Oncogene; 2008 Mar; 27(11):1618-28. PubMed ID: 17828297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of xCT expression and system x (c) (-) function in neuronal cells.
    Lewerenz J; Maher P; Methner A
    Amino Acids; 2012 Jan; 42(1):171-9. PubMed ID: 21369940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
    Chaturvedi RK; Shukla S; Seth K; Chauhan S; Sinha C; Shukla Y; Agrawal AK
    Neurobiol Dis; 2006 May; 22(2):421-34. PubMed ID: 16480889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of iptakalim on extracellular glutamate and dopamine levels in the striatum of unilateral 6-hydroxydopamine-lesioned rats: a microdialysis study.
    Yang J; Hu LF; Liu X; Zhou F; Ding JH; Hu G
    Life Sci; 2006 Mar; 78(17):1940-4. PubMed ID: 16216278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. beta-N-methylamino-l-alanine induces oxidative stress and glutamate release through action on system Xc(-).
    Liu X; Rush T; Zapata J; Lobner D
    Exp Neurol; 2009 Jun; 217(2):429-33. PubMed ID: 19374900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
    Matsuura K; Makino H; Ogawa N
    Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells.
    Bridges CC; Kekuda R; Wang H; Prasad PD; Mehta P; Huang W; Smith SB; Ganapathy V
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):47-54. PubMed ID: 11133847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary restriction affects striatal glutamate in the MPTP-induced mouse model of nigrostriatal degeneration.
    Holmer HK; Keyghobadi M; Moore C; Menashe RA; Meshul CK
    Synapse; 2005 Aug; 57(2):100-12. PubMed ID: 15906381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signalling through phospholipase C beta 4 is not essential for midbrain dopaminergic neuron survival.
    Smits SM; van der Nobelen S; Hornman KJ; von Oerthel L; Burbach JP; Smidt MP
    Neuroscience; 2005; 136(1):171-9. PubMed ID: 16198487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.